Sopharma AD (BUL:SFA)

Sopharma AD Cash Flow Statement

Financials in millions EUR. Fiscal year is January - December.

Operating Activities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Net Income	80.63	68.3	39.12	49.07	36.36	45.77
Depreciation & Amortization	39.9	38.07	28.27	26.62	24.98	25.89
Other Amortization	3.05	2.35	2.15	1.99	1.72	1.37
Asset Writedown & Restructuring Costs	0.15	0.15	0.13	-	-	-
Other Operating Activities	-81.19	-99.39	-30.34	-54.66	-6.78	-111.86
Operating Cash Flow	42.54	9.49	39.33	23.02	56.27	-38.85
Operating Cash Flow Growth	-59.05%	-75.87%	70.83%	-59.09%	-	-

Investing Activities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Capital Expenditures	-23.14	-23.02	-17.37	-12.47	-9.89	-10.41
Sale of Property, Plant & Equipment	0.76	0.65	1.47	7.68	0.98	0.54
Cash Acquisitions	-0.61	-0.67	-7.47	-4.78	-1.2	-1.2
Divestitures	5.78	5.67	-0.12	-	0.2	-0.59
Sale (Purchase) of Intangibles	-54.55	-50.05	-44.86	-9.66	-2.2	-3.46
Sale (Purchase) of Real Estate	0.18	0.18	-	-	-	1
Investment in Securities	4.23	2.46	-4.01	-19.4	-8.45	-20.91
Other Investing Activities	-0.28	-0.17	29.79	8.9	-10.96	-1.2
Investing Cash Flow	-64.26	-61.72	-45.16	-32.13	-32.51	-34.81

Financing Activities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Short-Term Debt Issued	-	60.53	17.62	22.53	15.83	109.16
Long-Term Debt Issued	-	22	73.51	18.69	1.11	8.61
Total Debt Issued	55.5	82.54	91.13	41.23	16.93	117.76
Short-Term Debt Repaid	-	-3.31	-17.51	-0.61	-30.2	-13.88
Long-Term Debt Repaid	-	-33.08	-45.52	-15.51	-18.46	-20.39
Total Debt Repaid	-54.69	-36.39	-63.03	-16.12	-48.65	-34.28
Net Debt Issued (Repaid)	0.81	46.15	28.1	25.11	-31.72	83.49
Issuance of Common Stock	37.93	33.53	16.73	79.8	-	-
Repurchase of Common Stock	-0	-0	-0	-2.69	-0.98	-8.5
Common Dividends Paid	-22.96	-6.96	-86.34	-36.76	-0.01	-0.03
Other Financing Activities	1.75	-2.09	-0.46	-0.62	-0.18	5.13
Financing Cash Flow	17.53	70.63	-41.97	64.85	-32.89	80.08

Net Cash Flow

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Net Cash Flow	-4.19	18.4	-47.8	55.74	-9.13	6.43

Free Cash Flow

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Free Cash Flow	19.4	-13.53	21.96	10.55	46.38	-49.25
Free Cash Flow Growth	-77.42%	-	108.11%	-77.25%	-	-
Free Cash Flow Margin	1.39%	-1.00%	1.99%	1.09%	5.43%	-5.98%
Free Cash Flow Per Share	0.05	-0.04	0.04	0.03	0.12	-0.13
Levered Free Cash Flow	-85.18	-93.12	-61.37	63.02	53.04	43.55
Unlevered Free Cash Flow	-78.06	-86.25	-57.23	66.53	54.96	47

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash Interest Paid	10.13	9.91	7.59	5.42	3.27	4.69
Cash Income Tax Paid	64.66	61.69	37.51	6.86	5.04	4.04

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 2, 2026

Data Sources Report a data error